• Jul 18, 2026 Wintrobe Hematology Chronic Myeloid Leukemia cytogenetic, and molecular remissions in the majority of patients. The distinction between complete hematologic response (CHR), complete cytogenetic response (CCyR), and major molecular response (MMR) is critical for long-term disease control. However, resistanc By Franz Friesen
• Dec 9, 2025 Hairy Cell Leukemia A Rare Case Report ment, offering high rates of durable remission. Current Therapeutic Approaches Purine Nucleoside Analogues: Cladribine remains the frontline therapy, 1. achieving complete remission in over 80% of patients. Its administration is typically a single 5- to 7-day cour By Julian Dicki
